iifl-logo

Balaxi Pharmaceuticals Ltd Board Meeting

55.16
(-3.16%)
Apr 30, 2025|03:55:17 PM

Balaxi Pharma CORPORATE ACTIONS

30/04/2024calendar-icon
30/04/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting10 Feb 20251 Feb 2025
To consider and approve the financial results for the period ended December 31, 2024 and other business matters BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding outcome of Board meeting held on February 10, 2025. (As Per NSE Announcement Dated on: 10.02.2025) BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Submission of the unaudited financial results for the quarter and nine months ended 31.12.2024 in Machine Readable form/Legible Copy. (As Per NSE Announcement Dated on: 05.03.2025)
Board Meeting5 Nov 202429 Oct 2024
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Other business. BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Outcome of the Board meeting held on November 05, 2024. (As Per NSE Announcement Dated on: 05/11/2024)
Board Meeting2 Aug 202425 Jul 2024
To consider and approve the financial results for the period ended Jun 30, 2024. BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Board meeting held on August 02, 2024. BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended June 30, 2024. (As Per NSE Announcement Dated on: 02/08/2024)
Board Meeting29 May 202421 May 2024
To consider and approve the financial results for the period ended March 31, 2024 BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Outcome of Board Meeting held on May 29, 2024. (As Per NSE Announcement Dated on: 29/05/2024)

Balaxi Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.